2014

Drug Delivery: Surveying the Global Competitive Landscape

NEW YORK, Dec. 12, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Drug Delivery: Surveying the Global Competitive Landscape

http://www.reportlinker.com/p01054658/Drug-Delivery-Surveying-the-Global-Competitive-Landscape .html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Delivery_Technology

The importance of drug delivery technology grows ever more acute; commercial and industry interest is continuing to build. The benefits to patients can be seen in improved medical outcomes, while the pharmaceutical industry is able to extend patent protection through novel delivery regimes, bringing new therapies to the market that would, previously, have been impossible to administer.

This new, richly-detailed report provides the most comprehensive review of the sector and examines the competitive drug delivery landscape with analysis of 112 key companies. The company landscape is always on the move: some have been bought by the big players, whilst others have just run out of money and gone to the wall. Slowly but surely the private equity groups - most of whom have been in relative hibernation for the past couple of years - are gradually returning to the fold and kick-starting the impetus for capital investment.

This report provides you with key data for each featured company...

Company Overview & Technology Focus

Key Personnel

Competition & Competing Products

Key Milestones

Products/Technologies

R&D & Research Strategy

Key Agreements & Alliances

Financial Data (where available)

Comprehensive Contact Details

The ability to readily assess the companies involved, research areas of interest, products being developed, strategic collaborations and performance is key to understanding this market. In 670+ information-packed pages, this new report Drug Delivery: Surveying the global competitive landscape 2012 (published February 2012) evaluates companies large and small from multinationals to specialist development and technology businesses. All major technology areas such as Controlled-release, Nucleic acid, Nano-enabled and Targeted delivery are covered.

Related Publications

Drug Delivery Insight

Whether your interest is commercial, financial, scientific or technological, no other business publication comes close to Drug Delivery Insight for providing such a comprehensive overview of the latest developments in every area of drug delivery. Available in print or updated regularly online.

Emerging Drug Delivery Technologies & Strategies: Players, Pipelines and Partnerships

This 3-volume 185-page report is essential for commercial business analysts, research planners and new product development specialists. Anyone who needs to understand the future outlook for, and competitive environment in, the global drug delivery market will benefit.

Drug Delivery Technologies: Advanced Oral & Parenteral

This major 2-volume report is essential reading for everyone in the drug delivery field, from niche technology specialists in the investment community and the pharmaceutical industry.

Medical Device Companies Analysis

A unique reporting service providing a complete appraisal of leading medical device companies worldwide, from 5-year financial review to analysis of significant strategic alliances and research portfolios.

This report details some of the most exciting technology out there and the companies involved.

Table of Contents

3M DRUG DELIVERY SYSTEMS 1

KEY PERSONNEL 1

COMPANY OVERVIEW1

KEY MILESTONES 1

PRODUCTS / TECHNOLOGIES2

AGREEMENTS6

KEY FINANCIAL DATA 7

COMPETITION 7

ACCESS PHARMACEUTICALS INC 9

KEY PERSONNEL 9

COMPANY OVERVIEW9

KEY MILESTONES 9

PRODUCTS / TECHNOLOGIES 10

RESEARCH ACTIVITIES 12

AGREEMENTS 15

KEY FINANCIAL DATA17

COMPETITION17

ACRUX LTD 19

KEY PERSONNEL 19

COMPANY OVERVIEW 19

KEY MILESTONES19

PRODUCTS / TECHNOLOGIES 20

RESEARCH ACTIVITIES 21

AGREEMENTS 21

KEY FINANCIAL DATA22

ACURA PHARMACEUTICALS23

KEY PERSONNEL 23

COMPANY OVERVIEW 23

KEY MILESTONES23

PRODUCTS / TECHNOLOGIES 23

RESEARCH ACTIVITIES 25

AGREEMENTS 25

KEY FINANCIAL DATA25

COMPETITION25

ALKERMES INC 27

KEY PERSONNEL 27

COMPANY OVERVIEW 27

KEY MILESTONES27

PRODUCTS / TECHNOLOGIES 28

PRODUCTS / TECHNOLOGIES (Elan Drug Technologies) 29

RESEARCH ACTIVITIES 32

AGREEMENTS 38

KEY FINANCIAL DATA39

COMPETITION39

ALLERGY THERAPEUTICS 41

KEY PERSONNEL 41

COMPANY OVERVIEW 41

KEY MILESTONES41

PRODUCTS / TECHNOLOGIES 42

RESEARCH ACTIVITIES44

AGREEMENTS44

KEY FINANCIAL DATA 45

COMPETITION 45

APRICUS BIOSCIENCES INC 47

KEY PERSONNEL 47

COMPANY OVERVIEW 47

KEY MILESTONES 47

PRODUCTS / TECHNOLOGIES48

RESEARCH ACTIVITIES 49

AGREEMENTS 50

KEY FINANCIAL DATA 51

COMPETITION 52

APTALIS PHARMA 53

KEY PERSONNEL 53

COMPANY OVERVIEW 53

KEY MILESTONES 53

PRODUCTS / TECHNOLOGIES54

AGREEMENTS 56

KEY FINANCIAL DATA 57

Aptar Group 59

KEY PERSONNEL 59

COMPANY OVERVIEW 59

KEY MILESTONES 59

PRODUCTS / TECHNOLOGIES 59

KEY FINANCIAL DATA 60

COMPETITION 60

ARADIGM CORPORATION 61

KEY PERSONNEL 61

COMPANY OVERVIEW 61

KEY MILESTONES 61

PRODUCTS / TECHNOLOGIES 62

RESEARCH ACTIVITIES 62

KEY FINANCIAL DATA 64

COMPETITION 64

ARCHIMEDES PHARMA 65

KEY PERSONNEL 65

COMPANY OVERVIEW 65

KEY MILESTONES 65

PRODUCTS / TECHNOLOGIES66

RESEARCH STRATEGY 68

AGREEMENTS68

KEY FINANCIAL DATA 69

ATLANTIC PHARMACEUTICALS 71

KEY PERSONNEL 71

COMPANY OVERVIEW 71

KEY MILESTONES 71

PRODUCTS / TECHNOLOGIES 71

KEY FINANCIAL DATA 72

COMPETITION 72

BAXA CORPORATION 73

KEY PERSONNEL 73

COMPANY OVERVIEW 73

KEY MILESTONES 73

PRODUCTS / TECHNOLOGIES 74

AGREEMENTS 76

KEY FINANCIAL DATA 76

BAXTER INTERNATIONAL INC 77

KEY PERSONNEL 77

COMPANY OVERVIEW 77

KEY MILESTONES 77

PRODUCTS / TECHNOLOGIES 78

RESEARCH ACTIVITIES 83

AGREEMENTS 83

KEY FINANCIAL DATA 84

COMPETITION 85

BIODELIVERY SCIENCES INTERNATIONAL 87

KEY PERSONNEL 87

COMPANY OVERVIEW 87

KEY MILESTONES 87

PRODUCTS / TECHNOLOGIES88

RESEARCH ACTIVITIES90

AGREEMENTS 91

KEY FINANCIAL DATA 92

ASSOCIATED COMPANIES 92

COMPETITION 92

BIOJECT MEDICAL TECHNOLOGIES INC 93

KEY PERSONNEL 93

COMPANY OVERVIEW 93

KEY MILESTONE 93

PRODUCTS / TECHNOLOGIES 93

RESEARCH ACTIVITIES94

AGREEMENTS96

KEY FINANCIAL DATA 97

COMPETITION 97

BIO-PATH HOLDINGS 99

KEY PERSONNEL 99

COMPANY OVERVIEW99

KEY MILESTONES 99

PRODUCTS / TECHNOLOGIES99

RESEARCH ACTIVITIES 101

AGREEMENTS 101

KEY FINANCIAL DATA 102

COMPETITION 102

BIOSANTE PHARMACEUTICALS INC 103

KEY PERSONNEL 103

COMPANY OVERVIEW 103

KEY MILESTONES 103

PRODUCTS / TECHNOLOGIES 104

RESEARCH ACTIVITIES 106

AGREEMENTS 108

KEY FINANCIAL DATA109

COMPETITION109

CALANDO PHARMACEUTICALS 111

KEY PERSONNEL111

COMPANY OVERVIEW 111

KEY MILESTONES 111

PRODUCTS / TECHNOLOGIES 111

RESEARCH ACTIVITIES 113

AGREEMENTS 113

KEY FINANCIAL DATA 114

CAMURUS AB 115

KEY PERSONNEL115

COMPANY OVERVIEW 115

KEY MILESTONES 115

PRODUCTS / TECHNOLOGIES 116

RESEARCH ACTIVITIES 118

AGREEMENTS 119

KEY FINANCIAL DATA 119

CAREFUSION121

KEY PERSONNEL 121

COMPANY OVERVIEW 121

KEY MILESTONES 121

PRODUCTS 121

AGREEMENTS 124

KEY FINANCIAL DATA 124

COMPETITION 124

CELATOR PHARMACEUTICALS INC 125

KEY PERSONNEL 125

COMPANY OVERVIEW 125

KEY MILESTONES 125

PRODUCTS / TECHNOLOGIES 126

R&D ACTIVITIES 127

AGREEMENTS 128

KEY FINANCIAL DATA 129

CELL THERAPEUTICS INC 131

KEY PERSONNEL 131

COMPANY OVERVIEW 131

KEY MILESTONES 131

PRODUCTS / TECHNOLOGIES 132

RESEARCH ACTIVITIES 133

AGREEMENTS 135

KEY FINANCIAL DATA 136

CEPHALON137

KEY PERSONNEL 137

COMPANY OVERVIEW 137

KEY MILESTONES 137

PRODUCTS 138

R&D ACTIVITIES 139

AGREEMENTS 141

KEY FINANCIAL DATA 143

COMPETITION 143

CIPHER PHARMACEUTICALS 145

KEY PERSONNEL 145

COMPANY OVERVIEW 145

KEY MILESTONES 145

PRODUCTS/TECHNOLOGIES 146

R&D MILESTONES 147

AGREEMENTS 147

KEY FINANCIAL DATA148

COLUMBIA LABORATORIES INC 149

KEY PERSONNEL 149

COMPANY OVERVIEW 149

KEY MILESTONES 149

PRODUCTS / TECHNOLOGIES 149

RESEARCH ACTIVITIES 151

AGREEMENTS 152

KEY FINANCIAL DATA 153

COMPETITION 154

CONSORT MEDICAL PLC 155

KEY PERSONNEL 155

COMPANY OVERVIEW 155

KEY MILESTONES 155

PRODUCTS / TECHNOLOGIES 155

RESEARCH ACTIVITIES 157

AGREEMENTS 157

KEY FINANCIAL DATA 158

COMPETITION 158

CORNERSTONE THERAPEUTICS 159

KEY PERSONNEL 159

COMPANY OVERVIEW 159

KEY MILESTONES 159

PRODUCTS 160

RESEARCH ACTIVITIES 161

AGREEMENTS 162

KEY FINANCIAL DATA 162

CPEX PHARMACEUTICALS INC 163

KEY PERSONNEL 163

COMPANY OVERVIEW 163

KEY MILESTONES 163

PRODUCTS / TECHNOLOGIES 164

RESEARCH ACTIVITIES 164

AGREEMENTS 165

KEY FINANCIAL DATA166

COMPETITION166

DEBIOPHARM SA 167

KEY PERSONNEL 167

COMPANY OVERVIEW 167

KEY MILESTONES 167

PRODUCTS / TECHNOLOGIES 168

RESEARCH ACTIVITIES 169

AGREEMENTS 170

KEY FINANCIAL DATA 171

ASSOCIATED COMPANIES 171

DELCATH SYSTEMS INC173

KEY PERSONNEL 173

COMPANY OVERVIEW 173

KEY MILESTONES 173

RESEARCH ACTIVITIES 174

AGREEMENTS 176

KEY FINANCIAL DATA 176

COMPETITION 177

DEPOMED INC179

KEY PERSONNEL 179

COMPANY OVERVIEW 179

KEY MILESTONES 179

PRODUCTS / TECHNOLOGIES 180

RESEARCH ACTIVITIES 181

AGREEMENTS 182

KEY FINANCIAL DATA 183

COMPETITION 183

DURECT CORPORATION 185

KEY PERSONNEL 185

COMPANY OVERVIEW 185

KEY MILESTONES 185

PRODUCTS / TECHNOLOGIES 186

AGREEMENTS 190

KEY FINANCIAL DATA 191

ASSOCIATED COMPANIES 191

COMPETITION 192

DUSA PHARMACEUTICALS INC 193

KEY PERSONNEL 193

COMPANY OVERVIEW 193

PRODUCTS / TECHNOLOGIES 193

RESEARCH ACTIVITIES 194

AGREEMENTS 195

KEY FINANCIAL DATA196

COMPETITION196

ECHO THERAPEUTICS197

KEY PERSONNEL 197

COMPANY OVERVIEW 197

KEY MILESTONES 197

PRODUCTS / TECHNOLOGIES 197

RESEARCH ACTIVITIES 199

AGREEMENTS 200

KEY FINANCIAL DATA201

COMPETITION201

ELITE PHARMACEUTICALS INC 203

KEY PERSONNEL 203

COMPANY OVERVIEW 203

KEY MILESTONES203

PRODUCTS / TECHNOLOGIES 204

RESEARCH ACTIVITIES 204

AGREEMENTS 205

KEY FINANCIAL DATA206

COMPETITION206

EGEN INC 207

KEY PERSONNEL 207

COMPANY OVERVIEW 207

PRODUCTS/TECHNOLOGIES 207

RESEARCH ACTIVITIES 208

AGREEMENTS 209

KEY FINANCIAL DATA209

EMISPHERE TECHNOLOGIES INC 211

KEY PERSONNEL211

COMPANY OVERVIEW 211

KEY MILESTONES 211

PRODUCTS / TECHNOLOGIES 211

RESEARCH ACTIVITIES 215

AGREEMENTS 215

KEY FINANCIAL DATA 216

COMPETITION 216

ENCAP DRUG DELIVERY 217

KEY PERSONNEL 217

COMPANY OVERVIEW 217

PRODUCTS / TECHNOLOGIES 217

AGREEMENTS 219

KEY FINANCIAL DATA 219

ENDO PHARMACEUTICALS 221

KEY PERSONNEL 221

COMPANY OVERVIEW 221

KEY MILESTONES221

TECHNOLOGIES/PRODUCTS 222

R&D MILESTONES (Endo) 227

AGREEMENTS 229

AGREEMENTS (Penwest)230

COMPETITION230

KEY FINANCIAL DATA 231

ENDOCYTE 233

KEY PERSONNEL 233

COMPANY OVERVIEW 233

KEY MILESTONES233

PRODUCTS / TECHNOLOGIES 233

RESEARCH ACTIVITIES 234

AGREEMENTS 236

KEY FINANCIAL DATA236

ENZON INC 237

KEY PERSONNEL 237

COMPANY OVERVIEW 237

KEY MILESTONES237

PRODUCTS / TECHNOLOGIES 238

RESEARCH ACTIVITIES 239

KEY FINANCIAL DATA 241

COMPETITION242

EPEIUS BIOTECHNOLOGIES INC 243

KEY PERSONNEL 243

COMPANY OVERVIEW 243

KEY MILESTONES243

PRODUCTS/TECHNOLOGIES 244

RESEARCH ACTIVITIES 245

KEY FINANCIAL DATA246

COMPETITION246

ETHYPHARM S/A 249

KEY PERSONNEL 249

COMPANY OVERVIEW 249

KEY MILESTONES249

PRODUCTS / TECHNOLOGIES 249

RESEARCH ACTIVITIES 252

AGREEMENTS 252

KEY FINANCIAL DATA253

FLAMEL TECHNOLOGIES INC 255

KEY PERSONNEL 255

COMPANY OVERVIEW 255

PRODUCTS / TECHNOLOGIES 255

R&D ACTIVITIES258

AGREEMENTS 259

KEY FINANCIAL DATA260

COMPETITION260

FZIOMED INC 261

KEY PERSONNEL 261

COMPANY OVERVIEW 261

KEY MILESTONES 261

PRODUCTS / TECHNOLOGIES 261

RESEARCH ACTIVITIES 263

KEY FINANCIAL DATA264

GENEREX BIOTECHNOLOGY CORPORATION 265

KEY PERSONNEL 265

COMPANY OVERVIEW 265

KEY MILESTONES265

PRODUCTS / TECHNOLOGIES 266

RESEARCH ACTIVITIES 267

AGREEMENTS 270

KEY FINANCIAL DATA271

COMPETITION272

GILEAD SCIENCES 273

KEY PERSONNEL 273

COMPANY OVERVIEW 273

KEY MILESTONES273

PRODUCTS / TECHNOLOGIES 274

RESEARCH ACTIVITIES 277

AGREEMENTS 282

KEY FINANCIAL DATA284

HOSPIRA 285

KEY PERSONNEL 285

COMPANY OVERVIEW 285

KEY MILESTONES285

PRODUCTS / TECHNOLOGIES 286

RESEARCH ACTIVITIES 289

AGREEMENTS 290

KEY FINANCIAL DATA291

IMMUNOGEN 293

KEY PERSONNEL 293

COMPANY OVERVIEW 293

KEY MILESTONES293

PRODUCTS / TECHNOLOGIES 293

RESEARCH ACTIVITIES 294

AGREEMENTS 297

KEY FINANCIAL DATA298

IMPAX LABORATORIES 299

KEY PERSONNEL 299

COMPANY OVERVIEW 299

KEY MILESTONES299

PRODUCTS / TECHNOLOGIES 300

RESEARCH ACTIVITIES 302

AGREEMENTS 303

KEY FINANCIAL DATA304

COMPETITION304

INNOCOLL TECHNOLOGIES 305

KEY PERSONNEL 305

COMPANY OVERVIEW 305

KEY MILESTONES305

PRODUCTS / TECHNOLOGIES 305

RESEARCH ACTIVITIES 307

AGREEMENTS 309

KEY FINANCIAL DATA 310

INOVIO PHARMACEUTICALS 311

KEY PERSONNEL311

COMPANY OVERVIEW 311

KEY MILESTONES 311

TECHNOLOGIES / PRODUCTS 311

RESEARCH ACTIVITIES 312

AGREEMENTS 315

KEY FINANCIAL DATA 317

KEY COMPETITION 317

INSITE VISION INC319

KEY PERSONNEL 319

COMPANY OVERVIEW 319

KEY MILESTONES 319

PRODUCTS / TECHNOLOGIES 319

RESEARCH ACTIVITIES 321

AGREEMENTS 323

KEY FINANCIAL DATA324

COMPETITION324

INSYS THERAPEUTICS 325

KEY PERSONNEL 325

COMPANY OVERVIEW 325

KEY MILESTONES325

PRODUCTS / TECHNOLOGIES 326

AGREEMENTS 328

KEY FINANCIAL DATA329

INTELGENX CORPORATION331

KEY PERSONNEL 331

COMPANY OVERVIEW 331

KEY MILESTONES 331

PRODUCTS / TECHNOLOGIES 332

RESEARCH ACTIVITIES 333

AGREEMENTS 334

KEY FINANCIAL DATA336

COMPETITION336

INTERCELL AG 337

KEY PERSONNEL 337

COMPANY OVERVIEW 337

KEY MILESTONES 337

PRODUCTS / TECHNOLOGIES 338

RESEARCH ACTIVITIES 339

AGREEMENTS 342

KEY FINANCIAL DATA342

COMPETITION343

KV PHARMACEUTICAL COMPANY 345

KEY PERSONNEL 345

COMPANY OVERVIEW 345

KEY MILESTONES345

PRODUCTS / TECHNOLOGIES 346

AGREEMENTS 348

KEY FINANCIAL DATA349

COMPETITION349

LAVIPHARM GROUP351

KEY PERSONNEL 351

COMPANY OVERVIEW 351

KEY MILESTONES 351

PRODUCTS / TECHNOLOGIES 351

AGREEMENTS 353

KEY FINANCIAL DATA354

LIGHT SCIENCES ONCOLOGY 355

KEY PERSONNEL 355

COMPANY OVERVIEW 355

PRODUCTS / TECHNOLOGIES 355

RESEARCH ACTIVITIES 356

AGREEMENTS 358

KEY FINANCIAL DATA358

MANNKIND CORPORATION 359

KEY PERSONNEL 359

COMPANY OVERVIEW 359

KEY MILESTONES359

PRODUCTS / TECHNOLOGIES 360

RESEARCH ACTIVITIES 362

AGREEMENTS 364

KEY FINANCIAL DATA365

COMPETITION365

Marina Biotech 367

KEY PERSONNEL 367

COMPANY OVERVIEW 367

KEY MILESTONES367

PRODUCTS / TECHNOLOGIES 368

RESEARCH ACTIVITIES 369

AGREEMENTS 372

KEY FINANCIAL DATA373

COMPETITION 374

MAXCYTE INC 375

KEY PERSONNEL 375

COMPANY OVERVIEW 375

PRODUCTS / TECHNOLOGIES 375

AGREEMENTS 377

KEY FINANCIAL DATA377

MEDIMMUNE INC 379

KEY PERSONNEL 379

COMPANY OVERVIEW 379

KEY MILESTONES379

PRODUCTS / TECHNOLOGIES 380

RESEARCH ACTIVITIES 381

AGREEMENTS 382

KEY FINANCIAL DATA383

COMPETITION383

MILESTONE SCIENTIFIC 385

KEY PERSONNEL 385

COMPANY BACKGROUND 385

KEY MILESTONES385

PRODUCTS / TECHNOLOGIES 385

AGREEMENTS 387

KEY FINANCIAL DATA388

COMPETITION388

MOOG MEDICAL DEVICES 389

KEY PERSONNEL 389

COMPANY OVERVIEW 389

KEY MILESTONES389

PRODUCTS / TECHNOLOGIES 389

AGREEMENTS 390

KEY FINANCIAL DATA 391

NANOBIOTIX 393

KEY PERSONNEL 393

COMPANY OVERVIEW 393

PRODUCTS / TECHNOLOGIES 393

RESEARCH ACTIVITIES 394

AGREEMENTS 394

KEY FINANCIAL DATA395

NANOMATERIALS TECHNOLOGY 397

KEY PERSONNEL 397

COMPANY OVERVIEW 397

KEY MILESTONES397

PRODUCTS / TECHNOLOGIES 397

AGREEMENTS 398

KEY FINANCIAL DATA398

NANOBIO CORPORATION 399

KEY PERSONNEL 399

COMPANY OVERVIEW 399

KEY MILESTONES399

PRODUCTS / TECHNOLOGIES 400

RESEARCH ACTIVITIES 401

AGREEMENTS 403

KEY FINANCIAL DATA404

NANOBIOMAGNETICS 405

KEY PERSONNEL 405

COMPANY OVERVIEW 405

PRODUCTS / TECHNOLOGIES 405

AGREEMENTS 406

KEY FINANCIAL DATA406

ASSOCIATED COMPANIES 407

NANOCARRIER 409

KEY PERSONNEL 409

COMPANY OVERVIEW 409

PRODUCTS / TECHNOLOGIES 409

RESEARCH ACTIVITIES 410

AGREEMENTS 411

KEY FINANCIAL DATA 413

NANOTHERAPEUTICS INC 415

KEY PERSONNEL 415

COMPANY OVERVIEW 415

KEY MILESTONES 415

PRODUCTS / TECHNOLOGIES 416

RESEARCH ACTIVITIES 419

AGREEMENTS 420

KEY FINANCIAL DATA 421

NEKTAR THERAPEUTICS 423

KEY PERSONNEL 423

COMPANY OVERVIEW 423

KEY MILESTONES423

PRODUCTS / TECHNOLOGIES 424

RESEARCH ACTIVITIES 425

AGREEMENTS 429

KEY FINANCIAL DATA430

ASSOCIATED COMPANIES 431

COMPETITION 431

NEUROGESX 433

KEY PERSONNEL 433

COMPANY OVERVIEW 433

KEY MILESTONES433

PRODUCTS / TECHNOLOGIES 433

RESEARCH STRATEGY 434

AGREEMENTS 434

KEY FINANCIAL DATA435

COMPETITION435

NEUROTECH 437

KEY PERSONNEL 437

COMPANY OVERVIEW 437

KEY MILESTONES437

PRODUCTS / TECHNOLOGIES 437

RESEARCH ACTIVITIES 439

AGREEMENTS 439

KEY FINANCIAL DATA440

ASSOCIATED COMPANIES 440

NOVADEL PHARMA 441

KEY PERSONNEL 441

COMPANY OVERVIEW 441

KEY MILESTONES441

PRODUCTS / TECHNOLOGIES 441

RESEARCH ACTIVITIES 442

AGREEMENTS 444

KEY FINANCIAL DATA445

COMPETITION445

NOVAVAX 447

KEY PERSONNEL 447

COMPANY OVERVIEW 447

KEY MILESTONES447

PRODUCTS / TECHNOLOGIES 448

RESEARCH ACTIVITIES 448

AGREEMENTS 451

KEY FINANCIAL DATA453

COMPETITION453

NOVEN PHARMACEUTICALS 455

KEY PERSONNEL 455

COMPANY OVERVIEW 455

KEY MILESTONES455

PRODUCTS / TECHNOLOGIES 455

RESEARCH ACTIVITIES 457

AGREEMENTS 457

KEY FINANCIAL DATA458

COMPETITION458

OCTOPLUS 459

KEY PERSONNEL 459

COMPANY OVERVIEW 459

KEY MILESTONES459

PRODUCTS / TECHNOLOGIES 459

AGREEMENTS 462

KEY FINANCIAL DATA463

OREXO 465

KEY PERSONNEL 465

COMPANY OVERVIEW 465

KEY MILESTONES465

PRODUCTS / TECHNOLOGIES 466

RESEARCH ACTIVITIES 469

AGREEMENTS 472

KEY FINANCIAL DATA473

COMPETITION 473

OTSUKA HOLDINGS475

KEY PERSONNEL 475

COMPANY OVERVIEW 475

KEY MILESTONES 475

PRODUCTS / TECHNOLOGIES 475

RESEARCH ACTIVITIES 480

AGREEMENTS 482

KEY FINANCIAL DATA483

PACIRA PHARMACEUTICALS INC 485

KEY PERSONNEL 485

COMPANY OVERVIEW 485

KEY MILESTONES485

PRODUCTS / TECHNOLOGIES 486

RESEARCH ACTIVITIES 487

AGREEMENTS 489

KEY FINANCIAL DATA489

COMPETITION489

PCI BIOTECH 491

KEY PERSONNEL 491

COMPANY OVERVIEW 491

KEY MILESTONES491

PRODUCTS / TECHNOLOGIES 491

RESEARCH ACTIVITIES 492

AGREEMENTS 493

KEY FINANCIAL DATA493

PEARL THERAPEUTICS 495

KEY PERSONNEL 495

COMPANY OVERVIEW 495

PRODUCTS / TECHNOLOGIES 495

RESEARCH STRATEGY 497

KEY FINANCIAL DATA498

PHOSPHAGENICS LIMITED 499

KEY PERSONNEL 499

COMPANY OVERVIEW 499

KEY MILESTONES499

TECHNOLOGIES / PRODUCTS 499

RESEARCH ACTIVITIES 502

AGREEMENTS 503

FINANCIALS 504

PHOTOCURE ASA 505

KEY PERSONNEL 505

COMPANY OVERVIEW 505

KEY MILESTONES505

PRODUCTS / TECHNOLOGIES 506

RESEARCH ACTIVITIES 507

AGREEMENTS 509

KEY FINANCIAL DATA 510

ASSOCIATED COMPANIES 510

POLYTHERICS LTD511

KEY PERSONNEL511

COMPANY OVERVIEW 511

KEY MILESTONES 511

PRODUCTS / TECHNOLOGIES 511

PRODUCTS 512

AGREEMENTS 513

KEY FINANCIAL DATA 514

pSIVIDA 515

KEY PERSONNEL 515

COMPANY OVERVIEW 515

KEY MILESTONES 515

TECHNOLOGIES / PRODUCTS 516

RESEARCH ACTIVITIES 517

AGREEMENTS 519

KEY FINANCIAL DATA 521

QLT 523

KEY PERSONNEL 523

COMPANY OVERVIEW 523

KEY MILESTONES523

PRODUCTS / TECHNOLOGIES 523

RESEARCH ACTIVITIES 524

AGREEMENTS 526

KEY FINANCIAL DATA527

COMPETITION527

QUEST PHARMATECH 529

KEY PERSONNEL 529

COMPANY OVERVIEW 529

KEY MILESTONES529

PRODUCTS / TECHNOLOGIES 529

RESEARCH ACTIVITIES 530

AGREEMENTS 531

KEY FINANCIAL DATA532

RAPTOR PHARMACEUTICALS 533

KEY PERSONNEL 533

COMPANY OVERVIEW 533

KEY MILESTONES533

PRODUCTS / TECHNOLOGIES 534

RESEARCH ACTIVITIES 536

AGREEMENTS 539

KEY FINANCIAL DATA540

COMPETITION540

RETRACTABLE TECHNOLOGIES INC 543

KEY PERSONNEL 543

COMPANY OVERVIEW 543

PRODUCTS / TECHNOLOGIES 543

LITIGATION UPDATE 544

KEY FINANCIAL DATA544

COMPETITION545

SAVARA PHARMACEUTICALS INC 547

KEY PERSONNEL 547

COMPANY OVERVIEW 547

KEY MILESTONES547

PRODUCTS / TECHNOLOGIES 548

KEY FINANCIAL DATA549

SCOLR PHARMA INC 551

KEY PERSONNEL 551

COMPANY OVERVIEW 551

KEY MILESTONES 551

PRODUCTS / TECHNOLOGIES 551

RESEARCH ACTIVITIES 552

AGREEMENTS 553

KEY FINANCIAL DATA554

COMPETITION554

SEATTLE GENETICS 555

KEY PERSONNEL 555

COMPANY OVERVIEW 555

KEY MILESTONES555

PRODUCTS / TECHNOLOGIES 556

RESEARCH ACTIVITIES 556

AGREEMENTS 560

KEY FINANCIAL DATA 561

COMPETITION562

SILENCE THERAPEUTICS 563

KEY PERSONNEL 563

COMPANY OVERVIEW 563

KEY MILESTONES563

PRODUCTS / TECHNOLOGIES 563

RESEARCH ACTIVITIES 564

AGREEMENTS 565

KEY FINANCIAL DATA566

SKINVISIBLE INC 567

KEY PERSONNEL 567

COMPANY OVERVIEW 567

KEY MILESTONES567

PRODUCTS / TECHNOLOGIES 567

RESEARCH ACTIVITIES 568

AGREEMENTS 569

KEY FINANCIAL DATA570

COMPETITION570

SKYEPHARMA PLC 573

KEY PERSONNEL 573

COMPANY OVERVIEW 573

KEY MILESTONES573

PRODUCTS / TECHNOLOGIES 574

RESEARCH ACTIVITIES 579

AGREEMENTS 581

KEY FINANCIAL DATA582

ASSOCIATED COMPANIES 582

COMPETITION582

SOLIGENIX 583

KEY PERSONNEL 583

COMPANY OVERVIEW 583

KEY MILESTONES583

PRODUCTS / TECHNOLOGIES 584

RESEARCH ACTIVITIES 587

AGREEMENTS 589

KEY FINANCIAL DATA590

COMPETITION590

STARPHARMA 593

KEY PERSONNEL 593

COMPANY OVERVIEW 593

KEY MILESTONES593

PRODUCTS / TECHNOLOGIES 593

RESEARCH ACTIVITIES 594

AGREEMENTS 596

KEY FINANCIAL DATA597

SUPRATEK PHARMA INC 599

KEY PERSONNEL 599

COMPANY OVERVIEW 599

KEY MILESTONES599

PRODUCTS / TECHNOLOGIES 599

RESEARCH ACTIVITIES 601

KEY FINANCIAL DATA601

TEKMIRA PHARMACEUTICALS CORPORATION 603

KEY PERSONNEL 603

COMPANY OVERVIEW 603

KEY MILESTONES603

PRODUCTS / TECHNOLOGIES 604

RESEARCH ACTIVITIES 606

AGREEMENTS 609

KEY FINANCIAL DATA 610

TELESSO TECHNOLOGIES611

KEY PERSONNEL611

COMPANY OVERVIEW 611

KEY MILESTONES 611

PRODUCTS / TECHNOLOGIES 611

RESEARCH ACTIVITIES 614

AGREEMENTS 615

KEY FINANCIAL DATA 615

ASSOCIATED COMPANIES 615

TRANSPHARMA MEDICAL 617

KEY PERSONNEL 617

COMPANY OVERVIEW 617

KEY MILESTONES 617

PRODUCTS / TECHNOLOGIES 617

RESEARCH ACTIVITIES 619

AGREEMENTS 621

KEY FINANCIAL DATA 621

TRIMEL PHARMACEUTICALS 623

KEY PERSONNEL 623

COMPANY OVERVIEW 623

KEY MILESTONES623

PRODUCTS / TECHNOLOGIES 623

RESEARCH ACTIVITIES 625

KEY FINANCIAL DATA626

COMPETITION626

UNILIFE 627

KEY PERSONNEL 627

COMPANY OVERVIEW 627

KEY MILESTONES627

PRODUCTS / TECHNOLOGIES 628

RESEARCH ACTIVITIES 629

AGREEMENTS 630

KEY FINANCIAL DATA630

COMPETITION 631

VALEANT PHARMACEUTICALS 633

KEY PERSONNEL 633

COMPANY OVERVIEW 633

KEY MILESTONES633

PRODUCTS / TECHNOLOGIES 634

RESEARCH ACTIVITIES 637

AGREEMENTS 638

KEY FINANCIAL DATA640

COMPETITION641

VECTURA LTD 643

KEY PERSONNEL 643

COMPANY OVERVIEW 643

KEY MILESTONES643

PRODUCTS / TECHNOLOGIES 643

RESEARCH ACTIVITIES 645

AGREEMENTS 648

KEY FINANCIAL DATA650

ASSOCIATED COMPANIES 650

VICAL INC 651

KEY PERSONNEL 651

COMPANY OVERVIEW 651

KEY MILESTONES 651

PRODUCTS / TECHNOLOGIES 651

RESEARCH ACTIVITIES 652

AGREEMENTS 655

KEY FINANCIAL DATA656

VIVUS INC 657

KEY PERSONNEL 657

COMPANY OVERVIEW 657

KEY MILESTONES657

PRODUCTS / TECHNOLOGIES 658

RESEARCH ACTIVITIES 661

AGREEMENTS 662

KEY FINANCIAL DATA662

COMPETITION662

ZOGENIX INC 663

KEY PERSONNEL 663

COMPANY OVERVIEW 663

KEY MILESTONES663

PRODUCTS / TECHNOLOGIES 664

RESEARCH ACTIVITIES 665

AGREEMENTS 666

KEY FINANCIAL DATA666

ZOSANO PHARMA 667

KEY PERSONNEL 667

COMPANY OVERVIEW 667

PRODUCTS / TECHNOLOGIES 667

RESEARCH ACTIVITIES 668

AGREEMENTS 669

KEY FINANCIAL DATA669

To order this report:

Drug_Delivery_Technology Industry: Drug Delivery: Surveying the Global Competitive Landscape

Contact Nicolas: nicolasbombourg@reportlinker.com
US: (805)-652-2626
Intl: +1 805-652-2626

SOURCE Reportlinker



RELATED LINKS
http://www.reportlinker.com

More by this Source


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

 

PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.